Severe acute respiratory syndrome coronavirus 2 (2019-nCoV), which first broke out in 1 Wuhan (China) in December of 2019, causes a severe acute respiratory illness with a mortality 2 ranging from 3% to 6%. To better understand the evolution of the newly emerging 2019-nCoV, in this 3 paper, we analyze the codon usage pattern of 2019-nCoV. For this purpose, we compare the codon 4 usage of 2019-nCoV with that of other 30 viruses belonging to the subfamily of orthocoronavirinae. 5 We found that 2019-nCoV shows a rich composition of AT nucleotides that strongly influences its 6 codon usage, which appears to be not optimized to human host. Then, we study the evolutionary 7 pressures influencing the codon usage and evolutionary rates of the sequences of five conserved 8 genes that encode the corresponding proteins (viral replicase, spike, envelope, membrane and 9 nucleocapsid) characteristic of coronaviruses. We found different patterns of both mutational bias 10 and nature selection that affect the codon usage of these genes at different extents. Moreover, we 11 show that the two integral membrane proteins proteins (matrix and envelope) tend to evolve slowly 12 by accumulating nucleotide mutations on their genes. Conversely, genes encoding nucleocapsid 13 (N), viral replicase and spike proteins are important targets for the development of vaccines and 14 antiviral drugs, tend to evolve faster as compared to other ones. Taken together, our results suggest 15 that the higher evolutionary rate observed for these two genes could represent a major barrier in the 16 development of antiviral therapeutics 2019-nCoV.